Trial
NCT01669720
Adjuvant Aflibercept for Metastatic Colorectal Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital; Lifespan; University of California, San Diego; Montefiore Medical Center; University of Florida; Sanofi
Condition
Metastatic Colorectal Cancer
Intervention
Aflibercept
Why stopped
Lack of efficacy and enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-17